We designed Fibrobodies®. These proprietary proteins bind selectively to so-called activated myofibroblasts in any type of fibrotic tissue. Fibrobodies® support conjugation of a wide range of payloads to create Fibrobody®-drug Conjugates. We are developing a line-up of Fibrobody®-drug conjugates for the diagnosis and treatment of fibrosis of the liver, kidney, lung and gut.
View Top Employees from LinXis Biopharmaceuticals| Website | http://www.linxispharmaceuticals.com |
| Revenue | $8 million |
| Employees | 19 (15 on RocketReach) |
| Founded | 2012 |
| Address | Cronenburg 75, Amsterdam, North Holland 1081GM, NL |
| Phone | +31 6 14204520 |
| Technologies |
JavaScript,
HTML,
Twitter
+12 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Pharmaceuticals, Healthcare |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular LinXis Biopharmaceuticals employee's phone or email?
LinXis Biopharmaceuticals Questions
The LinXis Biopharmaceuticals annual revenue was $8 million in 2024.
Bart Nijmeijer is the CEO of LinXis Biopharmaceuticals.
15 people are employed at LinXis Biopharmaceuticals.
LinXis Biopharmaceuticals is based in Amsterdam, North Holland.
The NAICS codes for LinXis Biopharmaceuticals are [541713, 54171, 5417, 54, 541].
The SIC codes for LinXis Biopharmaceuticals are [87, 873].
Top LinXis Biopharmaceuticals Employees
-
3
-
2
-
ViewYvet Noordman
Head of Pharmaceutical Development at LinXis Biopharmaceuticals
Amsterdam, North Holland, Netherlands4 -
21
-
2
-
1
-
1
Related Companies
